Literature DB >> 11316925

Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.

J P Moatti1, D Vlahov, I Feroni, V Perrin, Y Obadia.   

Abstract

OBJECTIVE: In Marseille, southeastern France, HIV prevention programs for injection drug users (IDUs) simultaneously include access to sterile syringes through needle exchange programs (NEPs), legal pharmacy sales and, since 1996, vending machines that mechanically exchange new syringes for used ones. The purpose of this study was to compare the characteristics of IDUs according to the site where they last obtained new syringes.
METHODS: During 3 days in September 1997, all IDUs who obtained syringes from 32 pharmacies, four NEPs and three vending machines were offered the opportunity to complete a self-administered questionnaire on demographics, drug use characteristics and program utilization.
RESULTS: Of 485 individuals approached, the number who completed the questionnaire was 141 in pharmacies, 114 in NEPs and 88 at vending machines (response rate = 70.7%). Compared to NEP users, vending machine users were younger and less likely to be enrolled in a methadone program or to report being HIV infected, but more likely to misuse buprenorphine. They also had lower financial resources and were less likely to be heroin injectors than both pharmacy and NEP users.
CONCLUSIONS: Our results suggest that vending machines attract a very different group of IDUs than NEPs, and that both programs are useful adjuncts to legal pharmacy sales for covering the needs of IDUs for sterile syringes in a single city. Assessment of the effectiveness and cost-effectiveness of combining such programs for the prevention of HIV and other infectious diseases among IDUs requires further comparative research. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11316925     DOI: 10.1159/000050713

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  17 in total

Review 1.  How can health services effectively meet the health needs of homeless people?

Authors:  Nat M J Wright; Charlotte N E Tompkins
Journal:  Br J Gen Pract       Date:  2006-04       Impact factor: 5.386

2.  Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.

Authors:  Ricky N Bluthenthal; Rachel Anderson; Neil M Flynn; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2007-02-05       Impact factor: 4.492

Review 3.  Prevention of HIV infection among injection drug users in resource-limited settings.

Authors:  David Vlahov; Angela M Robertson; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

Review 4.  Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Authors:  Michael A Yokell; Nickolas D Zaller; Traci C Green; Josiah D Rich
Journal:  Curr Drug Abuse Rev       Date:  2011-03

Review 5.  Why buprenorphine is so successful in treating opiate addiction in France.

Authors:  M Fatseas; Marc Auriacombe
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

6.  A multistate trial of pharmacy syringe purchase.

Authors:  Wilson M Compton; Joe C Horton; Linda B Cottler; Robert Booth; Carl G Leukefeld; Merrill Singer; Renee Cunningham-Williams; Wendy Reich; Karen Fortuin Corsi; Michele Staton; Joseph L Fink; Thomas J Stopka; Edward L Spitznagel
Journal:  J Urban Health       Date:  2004-12       Impact factor: 3.671

7.  Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Kristi Rüütel; Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2009-02-20

8.  Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002.

Authors:  Estelle Lavie; Mélina Fatséas; Jean-Pierre Daulouède; Cécile Denis; Jacques Dubernet; Laurent Cattan; Marc Auriacombe
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

Review 9.  Combination prevention: new hope for stopping the epidemic.

Authors:  Sten H Vermund; Richard J Hayes
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

10.  Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review.

Authors:  Md Mofizul Islam; Katherine M Conigrave
Journal:  Harm Reduct J       Date:  2007-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.